Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2010
09/15/2010CN101177426B Process for separating extracting spherosinin from gansu whin
09/15/2010CN101165063B Meliacarpinin derivatives, preparation method and use thereof
09/15/2010CN101125175B Fritillaria thunergii medicine composition for treating acute leukemia and its new use
09/15/2010CN101125016B Method for producing high selenium and germanium beverage
09/15/2010CN101057883B Medicinal composition with anti tumor function
09/14/2010US7795440 N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795407 Metastatic breast and colon cancer regulated genes
09/14/2010US7795391 Protein showing enhanced expression in cancer cells
09/14/2010US7795381 Helper T lymphocytes epitope for use in induction of antitumor responses in melanoma; antiproliferative agents
09/14/2010US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia
09/14/2010US7795264 Tyrosine kinase with immunoglobulin and epidermal growth factor homology domain signaling inhibitors; dysregulated vascular growth disorders
09/14/2010US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents
09/14/2010US7795249 Certain pyrazoline derivatives with kinase inhibitory activity
09/14/2010US7795248 tyrosine kinase inhibitors such as N-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-N'-phenylurea, used for treating benign or neoplastic proliferative diseases and autoimmune diseases; antitumor agents
09/14/2010US7795232 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
09/14/2010US7795206 Peptide that inhibits janus kinase
09/14/2010US7794995 use of several sequential steps, including subcellular fractionation to isolate a plasma membrane fraction and the use of gel filtration or chromatography that separates molecules according to their size or affinity; drug screening
09/14/2010US7794929 Detecting a colorectal cancer and/or gastric cancer, detecting selective hybridization of nucleic acid, therapeutic treatment of a cancer, a kit contains oligonucleotide
09/14/2010US7794747 Stabilization, homogenizing, sterile filtration, dehydration, reconstitution, ultrafiltration; storage stability; taxanes
09/14/2010US7794723 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination
09/14/2010US7794711 Agent for treating chondroma and chondrosarcoma
09/14/2010CA2479353C N-substituted benzothiophenesulfonamide derivative
09/14/2010CA2472335C Geranyl compounds
09/14/2010CA2458744C Anticancer agents and preparation method of the same
09/14/2010CA2454786C Pharmaceutical composition comprising (-)-secoisolariciresinol
09/14/2010CA2443623C A jasmonate pharmaceutical composition for treatment of cancer
09/14/2010CA2441501C Rho-kinase inhibitors
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/14/2010CA2393720C Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
09/14/2010CA2354210C Indole derivatives and their use as medicaments
09/14/2010CA2347913C Oral administration of adenosine analogs
09/14/2010CA2260291C Antagonists of intestinotrophic glp-2 peptides
09/14/2010CA2257821C Genes from 20q13 amplicon and their uses
09/14/2010CA2087883C Beta-alethine use in cell culture and therapy
09/10/2010WO2010102286A2 Proteasome inhibitors having chymotrypsin-like activity
09/10/2010WO2010102281A2 Inhibitors of anaphase promoting complex activity
09/10/2010WO2010102277A2 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
09/10/2010WO2010102219A1 Methylenedioxybenzo [i] phenanthridine derivatives used to treat cancer
09/10/2010WO2010102095A2 Kinase protein binding inhibitors
09/10/2010WO2010101994A2 Gene fusion targeted therapy
09/10/2010WO2010101964A2 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell
09/10/2010WO2010101949A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010WO2010101888A2 Methods and compositions for treatment of tumor metastasis
09/10/2010WO2010101849A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/10/2010WO2010101793A2 Methods and compositions for the diagnosis, prognosis and treatment of cancer
09/10/2010WO2010101353A2 Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer
09/10/2010WO2010101302A1 Thienopyrimidine as cdc7 kinase inhibitors
09/10/2010WO2010101257A1 Agent for preventing recurrence of leukemia
09/10/2010WO2010101249A1 Method for enhancing function of t cell
09/10/2010WO2010101248A1 Cell proliferation inhibitor and method for screening same
09/10/2010WO2010101178A1 Amino acid-conjugated cyanoacrylate polymer particles
09/10/2010WO2010101164A1 Pyridine derivative
09/10/2010WO2010101128A1 Amide compound
09/10/2010WO2010101127A1 Indole compound
09/10/2010WO2010100878A1 Vangl1 peptides and vaccines including the same
09/10/2010WO2010100686A1 Combination use of cholestanol derivative
09/10/2010WO2010100515A2 Fractions of wheat germ ferment
09/10/2010WO2010100431A1 Pyrrolopyrimidines used as kinase inhibitors
09/10/2010WO2010100404A2 Rna molecules and therapeutic uses thereof
09/10/2010WO2010100328A1 NUCLEIC ACIDS REGULATING OESTROGEN RECEPTOR (ER)-α SIGNALING IN BREAST CANCER
09/10/2010WO2010100297A1 Bisthiazole compounds that can be used to treat cancer
09/10/2010WO2010100248A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak)
09/10/2010WO2010100127A1 Disubstituted imidazole derivatives as modulators of raf kinase
09/10/2010WO2010100060A2 Method for increasing endogenous plasmalogen levels in mammals
09/10/2010WO2010099938A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010WO2010099918A1 Pharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient
09/10/2010WO2010099740A1 13a-(s) desoxytylophorinine derivatives, preparation method, pharmaceutical compositon and use thereof
09/10/2010WO2010099731A1 Compounds, compositions and use for anticancer therapy
09/10/2010WO2010099612A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010WO2010099601A1 Use of 5ahq and bortezomib for the treatment of hematological diseases
09/10/2010WO2010099600A1 Compounds and methods for treating cancer and viral infections
09/10/2010WO2010083441A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/10/2010WO2010078916A4 Immunocytokines for tumour therapy with chemotherapeutic agents
09/10/2010WO2010066868A3 Anti-igf antibodies
09/10/2010WO2010064838A3 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient
09/10/2010WO2010059004A3 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient
09/10/2010WO2010059001A3 Polymer micelle composition for treatment of resistant cancer cells
09/10/2010WO2010054328A3 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
09/10/2010WO2010053877A3 Mhc ii associated protein and uses thereof
09/10/2010WO2010053316A3 New use of sixth immunoglobulin-like domain of vcam-1
09/10/2010WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors
09/10/2010WO2010042163A3 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
09/10/2010WO2009070609A3 Therapeutic targeting of il-6 using sirna in neutral liposomes
09/10/2010CA2754834A1 Kinase protein binding inhibitors
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2754330A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010CA2754217A1 Methods and systems for treatment and/or diagnosis
09/10/2010CA2754075A1 Cholestanol derivative for combined use
09/10/2010CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators
09/10/2010CA2753681A1 Vangl1 peptides and vaccines including the same
09/10/2010CA2753637A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak)
09/10/2010CA2753621A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010CA2753552A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/10/2010CA2753236A1 Pyrrolopyrimidines used as kinase inhibitors
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100228007 Mhc-peptide complex binding ligands
09/09/2010US20100227919 Dioxaspiroketal Derivatives, Process for Their Preparation and Uses Thereof
09/09/2010US20100227910 Gene fusion targeted therapy
09/09/2010US20100227909 Compositions comprising mir34 therapeutic agents for treating cancer
1 ... 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 ... 2211